You’re offline. This is a read only version of the page.
Special thanks to our Platinum Sponsor Morgan Stanley
Registered attendees will receive an email with the subject line “Welcome to the State of Possible Conference 2020 - Event Access Link” from registrations@bizzabo.com.
The State of Possible Conference, MassBio's Annual Meeting, will now be hosted virtually on August 26-27, 2020. Featuring interactive networking and a groundbreaking viewer experience, this event will not be your average webinar.
We will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks®, inspiring and engaging content in the style of a TED Talk.
| Session Title | Start Time | End Time |
|---|---|---|
|
Welcome
|
8/26/2020 10:00 AM | 8/26/2020 10:30 AM |
|
Shifting the Drug Industry’s Public Narrative Through Stories of Success
Shifting the Drug Industry’s Public Narrative Through Stories of Success The COVID-19 pandemic has put a spotlight on the true value of the life sciences industry – every person in the world now knows what it feels like to live with an unmet medical need. Will this have a lasting impact on the reputation of the industry? This panel will address the evolving public opinion about drug prices, innovation, and the industry, and how first-hand experience of patients, employees, and physicians could be a critical piece of reframing the debate. |
8/26/2020 10:30 AM | 8/26/2020 11:15 AM |
|
Resilience, Grit, Freedom to Fail and Pivot
Biotech is not for the risk averse. Most successful entrepreneurs and investors have experienced multiple failures on their way to commercialization, and many have had to scrap what they were working on and start over. Beyond the statistics of scientific and clinical results missing desired endpoints, hear the personal stories of those who have lived the ups and downs of the long journey from intriguing science to patient bedside. |
8/26/2020 11:30 AM | 8/26/2020 12:00 PM |
|
Lifting the Curtain on R&D to Advance New Drug Targets Faster
Science is driven by reproducible experimental evidence under peer-review toward global consensus, and it’s full of trial-and-error. There has been a push by some to make that research – successes and failures – more transparent to prevent others from making the same mistakes or going after the wrong targets. What can our innovation ecosystem do to share findings widely, challenge engrained beliefs, and follow new avenues, all while preserving a competitive advantage that academic and industry research require? |
8/26/2020 11:30 AM | 8/26/2020 12:00 PM |
|
Innovative Leadership Award Presentation & Lunch
MassBio’s Innovative Leadership Award honors Dr. Abbie Celniker who has contributed significantly to the growth and success of the life sciences in Massachusetts, is a leader in her communities, and a leader for employees by creating a positive work environment. |
8/26/2020 12:15 PM | 8/26/2020 12:25 PM |
|
Possible Talk: Patient Stories - Lina Rebeiz's Road to Medical School
|
8/26/2020 12:45 PM | 8/26/2020 1:00 PM |
|
From Seed to Series A: Creative Ways to Fund Your Startup
The platform-based, venture-created, $100M+ Series A startup is now a fixture in Massachusetts biotech. However, most first-time founders come straight from academia and struggle to secure funding to demonstrate meaningful in-vivo efficacy of their product candidate. Since therapeutics' risk, time and scale of capital doesn't match the needs of angel investors, who will fund the next generation of great ideas and leaders? This panel will explore alternate forms of funding along with the critical role of mentors, advisory boards, and other support systems in navigating this landscape. |
8/26/2020 1:00 PM | 8/26/2020 1:30 PM |
|
Realities of Precision Medicine – How Small is Too Small?
The world of precision medicine has evolved dramatically over the years, with targeted treatment for specific patients dating back 2,500 years to Hippocrates. Although genetic and biomarker testing to guide treatment is possible, and in theory should improve care while lowering costs, barriers to widespread adoption remain. Hear from expert panelists as they offer competing views on the shifting paradigm, from biohackers and ultra-rare disease, to more mainstream targeting. How small is too small? |
8/26/2020 1:00 PM | 8/26/2020 1:30 PM |
|
Possible Talk: Empowering the Financial Lives of People & Companies
|
8/27/2020 10:00 AM | 8/27/2020 10:15 AM |
|
Supporting Regional Growth of the Life Sciences Beyond Cambridge
One of the greatest strengths of Kendall Square is the sheer density of biopharmas, research institutions, academic institutions, and proximity to the best academic medical centers in the world. Yet, the success of this mini cluster within Massachusetts is also its greatest weakness. Companies struggle to afford the real estate and employees are increasingly frustrated with their commutes and housing costs – leading more companies to move outside of Cambridge. This panel will address why this is a good thing, how to support the continued growth of the industry across Massachusetts, and what kinds of infrastructure investments must be made to ensure success. |
8/27/2020 10:15 AM | 8/27/2020 10:45 AM |
|
AI and Drug Discovery: Marrying Data Science with Core Biology
Machine learning and model-based drug discovery is rapidly becoming the norm. Computational biology is now integrating 'wet' in vitro/in vivo and 'dry' insilico biology accelerating and saving time and resources, at least in the early stages of drug discovery. This panel will explore the new world of digital biology as a way to model potential drug effects more accurately and quickly. |
8/27/2020 10:15 AM | 8/27/2020 10:45 AM |
|
Possible Talk: The Process of Turning What Ifs into Realities through the Life Sciences
|
8/27/2020 11:00 AM | 8/27/2020 11:15 AM |
|
State of Possible Award Presentation
|
8/27/2020 11:15 AM | 8/27/2020 11:30 AM |
|
Building a Digital Health Community in Massachusetts
The biopharma industry is increasingly utilizing digital technologies and digital health tools that promise to modernize drug discovery and development, along with patient care and measurement of patient outcomes. There has been continued focus on supporting this convergence in Massachusetts, both within the leading academic institutions and government, but there’s still much more than can be done to build a sustainable community here. This panel will draw insights from other clusters on how to support better connectivity and collaboration between digital health and the life sciences. |
8/27/2020 12:00 PM | 8/27/2020 12:30 PM |
|
Possible Talk: Determination Through Adversity
|
8/27/2020 12:45 PM | 8/27/2020 1:00 PM |
|
KEYNOTE: Leading in 21st Century Technologies: Our Products and Our People
|
8/27/2020 12:45 PM | 8/27/2020 1:15 PM |